Inventor
YEO YOON
KR14 patents
⚠️ This page may combine multiple inventors who share the name “YEO YOON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PURDUE RESEARCH FOUNDATION
12 patentsUS6599627B2Jul 29, 2003
Microencapsulation of drugs by solvent exchange
PURDUE RESEARCH FOUNDATION104 citations96
US6767637B2Jul 27, 2004
Microencapsulation using ultrasonic atomizers
PURDUE RESEARCH FOUNDATION64 citations95
US10526605B2Jan 7, 2020
siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
PURDUE RESEARCH FOUNDATION34 citations90
US11154514B2Oct 26, 2021
Quinic acid-modified nanoparticles and uses thereof
PURDUE RESEARCH FOUNDATION0 citations62
US11793982B2Oct 24, 2023
Drug delivery devices and methods of fabrication and use therefor
PURDUE RESEARCH FOUNDATION0 citations61
US11028393B2Jun 8, 2021
siRNA compositions that specifically down regulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease
PURDUE RESEARCH FOUNDATION0 citations59
US11865158B2Jan 9, 2024
Process and composition matter of nanoparticle formulation for systemic treatment of sepsis
PURDUE RESEARCH FOUNDATION0 citations52
US10398651B2Sep 3, 2019
Carrier-free nanoparticles
PURDUE RESEARCH FOUNDATION0 citations52
US9962401B2May 8, 2018
Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
PURDUE RESEARCH FOUNDATION0 citations49
US9517246B2Dec 13, 2016
Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
PURDUE RESEARCH FOUNDATION0 citations49
US9393262B2Jul 19, 2016
Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
PURDUE RESEARCH FOUNDATION1 citations49
US10036024B2Jul 31, 2018
siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
PURDUE RESEARCH FOUNDATION0 citations48